CORAL GABLES, Fla., Aug. 14, 2023 Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel. -Today at 08:06 am- MarketScreener
In patients with multiple sclerosis being treated with anti-CD20 therapy, there was no significant increase in protection from receiving a third SARS-CoV-2 mRNA vaccination in a prospective observational study.